Amino acids and KLHL22 do not activate mTORC1 via DEPDC5 degradation
- PMID: 39780017
- DOI: 10.1038/s41586-024-07974-0
Amino acids and KLHL22 do not activate mTORC1 via DEPDC5 degradation
Conflict of interest statement
Competing interests: D.M.S. is a shareholder of Navitor Pharmaceuticals, which is targeting for therapeutic benefit the amino-acid-sensing pathway upstream of mTORC1.
Comment on
-
KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing.Nature. 2018 May;557(7706):585-589. doi: 10.1038/s41586-018-0128-9. Epub 2018 May 16. Nature. 2018. PMID: 29769719
References
Publication types
LinkOut - more resources
Full Text Sources